ConserV Says Its Vaccine R&D Is 'Aimed At The Next Pandemic’

Enters mRNA Pact with Belgium’s eTheRNA Targeting Highly Mutagenic Viruses

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.